Skip to main content
Clinical Trials/CTRI/2022/07/044160
CTRI/2022/07/044160
Not yet recruiting
Phase 2

RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFICACY OF ARAGWADHADI TAILA IN COMPARISON WITH BETADINE LIQUID IN THE MANAGEMENT OF DUSHTA VRANA.

DR AMRUTA ARVIND NARKAR0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Sponsor
DR AMRUTA ARVIND NARKAR
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
DR AMRUTA ARVIND NARKAR

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients having sign and symptoms of Dushta Vrana i.e.infected wound.
  • 2\.Dushta Vrana size up to 5Ã?5cms (LxB)
  • 3\.Patients of either sex will be selected.
  • 4\.The patients of age group 19 \- 70 years

Exclusion Criteria

  • 1\.Anaemic patient Hb \< 10 gm
  • 2\.Malnourished patient (as per age, height and weight proportion)
  • 3\.Bleeding disorders (increased B.T and C.T)
  • 4\.Patient with septicemia
  • 5\.The patients suffering from systemic disease such as AIDS, Tuberculosis, Uncontrolled Diabetes mellitus, Hepatitis\-B, Malignancy, Vericose ulcer, Deep vein thrombosis, Neurogenic ulcer, Leukemia, etc.
  • 6\.Any congenital diseases or abnormalities.

Outcomes

Primary Outcomes

Not specified

Similar Trials